Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Why AGI Is Impossible

As a listener of TOE you can get a special 20% off discount to The Economist and all it has to offer! Visit https://www.economist.com/toe.

Join My New Substack (Personal Writings): https://curtjaimungal.substack.com.

Listen on Spotify: https://tinyurl.com/SpotifyTOE

Become a YouTube Member (Early Access Videos):
https://www.youtube.com/channel/UCdWIQh9DGG6uhJk8eyIFl1w/join.

Support TOE on Patreon: https://patreon.com/curtjaimungal.

Twitter: https://twitter.com/TOEwithCurt.

How Epigenetic Reprogramming Makes Cells Act Young Again

Aging doesn’t rewrite your DNA, it scrambles how your cells read it.

This clip explains epigenetic drift and how Life Biosciences’ therapy, ER100, uses Yamanaka factors to restore youthful epigenetic patterns in aged cells. By resetting the chemical marks that control gene expression, cells can behave as if they’re young again without changing the underlying DNA.

It’s the same biological process that happens early in embryonic development, applied in a controlled way to adult cells.

Abstract: In a cohort of over 1,000 patients with BreastCancer

Emilio Hirsch & team identify SH3BP5L as the most highly expressed guanine nucleotide exchange factor (GEF) for RAB11A, and its inhibition lowers lung metastasis and cell spreading in triple negative breast cancer models (TNBC):

The figure shows immunohistochemical assessment of SH3BP5L expression in tissue from patients with breast cancer.

@unito.it @fondazioneumbertoveronesi


1Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center “G. Tarone,” University of Torino, Torino, Italy.

2IEO, European Institute of Oncology IRCCS, Milan, Italy.

3Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.

When water meets rock: Exploring water quality impacts from legacy lithium mining in North Carolina

Starting just outside Charlotte, North Carolina, a vast underground deposit of lithium stretches south for 25 miles. A key component of rechargeable batteries and energy grid storage systems, the soft, silvery metal is a global commodity, making this subterranean cache a geopolitically important and potentially lucrative resource.

Here, lithium primarily occurs within granite-like rocks called pegmatite, bound to a green-tinged mineral called spodumene. Two large lithium mines once operated in this region—called the Carolina Tin-Spodumene Belt—but closed decades ago. As demand for renewable energy climbs, mining companies have growing interest in the area.

The presence of historic, or legacy, lithium mines and the prospect of new lithium mining activity have led nearby residents to wonder about the possibility of drinking water contamination. Over the past several years, a team led by Avner Vengosh, Distinguished Professor and Nicholas Chair of Environmental Quality at Duke University’s Nicholas School of the Environment, has been working to address those concerns.

Antibodies block bacteria that cause tuberculosis, study shows

A study led by UT Southwestern Medical Center researchers has found that certain antibodies inhibit Mycobacterium tuberculosis, the cause of tuberculosis (TB), the infectious disease that claims the most lives worldwide. Published in Cell Reports, the study identified characteristics of these antibodies and revealed insights that may lead to clinical tools that help prevent TB and other diseases.

“This data changes how we think about using the immune system against tuberculosis by showing how some antibodies activate immune cells in patients to block Mycobacterium tuberculosis (Mtb),” said the study’s senior author, Lenette Lu, M.D., Ph.D., Assistant Professor of Internal Medicine and Immunology and a member of the Division of Infectious Diseases and Geographic Medicine at UT Southwestern.

Despite widespread use of Bacillus Calmette-Guérin (BCG), the only licensed TB vaccine, the Centers for Disease Control and Prevention (CDC) estimates that 10.8 million people became ill with TB in 2023 and 1.25 million died.

Humans will merge with AI in 10 years | Ray Kurzweil and Lex Fridman

Lex Fridman Podcast full episode: https://www.youtube.com/watch?v=ykY69lSpDdo.
Please support this podcast by checking out our sponsors:
- Shopify: https://shopify.com/lex to get 14-day free trial.
- NetSuite: http://netsuite.com/lex to get free product tour.
- Linode: https://linode.com/lex to get $100 free credit.
- MasterClass: https://masterclass.com/lex to get 15% off.
- Indeed: https://indeed.com/lex to get $75 credit.

GUEST BIO:
Ray Kurzweil is an author, inventor, and futurist.

PODCAST INFO:
Podcast website: https://lexfridman.com/podcast.
Apple Podcasts: https://apple.co/2lwqZIr.
Spotify: https://spoti.fi/2nEwCF8
RSS: https://lexfridman.com/feed/podcast/
Full episodes playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOdP_8GztsuKi9nrraNbKKp4
Clips playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOeciFP3CBCIEElOJeitOr41

SOCIAL:
- Twitter: https://twitter.com/lexfridman.
- LinkedIn: https://www.linkedin.com/in/lexfridman.
- Facebook: https://www.facebook.com/lexfridman.
- Instagram: https://www.instagram.com/lexfridman.
- Medium: https://medium.com/@lexfridman.
- Reddit: https://reddit.com/r/lexfridman.
- Support on Patreon: https://www.patreon.com/lexfridman

“The Bioelectric Interface to the Collective Intelligence of Morphogenesis” by Michael Levin

This is a ~57 minute talk titled “The Bioelectric Interface to the Collective Intelligence of Morphogenesis: development, regeneration, cancer, and beyond” which I gave at a UCSF seminar for an audience of graduate students and post-docs in Biophysics, Bioinformatics, and Chemical Biology. I covered the role of bioelectricity as cognitive glue underlying high-level adaptive plasticity in living tissue, recent progress in exploiting that interface, and new developments in research platforms for this field.

/* */